OTC Swine Flu Stocks Move Higher
Linkwell Corporation (LWLLE), NanoViricides Inc. (NNVC), MultiCell Technologies, Inc. (MCET), and Kiwa Bio-Tech Products Group Corporation (KWBTE) all moved higher on swine flu concerns worldwide.
Linkwell Corporation [[LWLLE.OB]] shares moved up more than 250 percent on speculation that demand for disinfectant products could rise in China. The company is the number one producer of disinfectants with 56 product lines in China, but still controls just a fraction of the $6.25 billion market. Investors are betting that the swine flu outbreak will generate demand for disinfectants in China and around the world.
NanoViricides Inc. [[NNVC.OB]] shares jumped more than 40 percent after it re-announced the development of its flu drugs. The company’s FluCide drug has reportedly been effective in targeting two key flu strains in animal testing, but the drug still has yet to go through FDA drug trials in order to be sold commercially. However, investors seem bullish that this drug will reshape the market for flu drugs when it is released.
MultiCell Technologies, Inc. [[MCET.OB]] shares surged more than 50 percent as investors seemed to recall its past press releases focused on the avian flu. The press release, dated October 21, 2005, announced pre-clinical test results showing positive results for H1N1 flu strains – the same strain as the swine flu. Shareholders are bullish that the company’s toll receptor technology will be able to show similar effectiveness with the swine flu.
Kiwa Bio-Tech Products Group Corporation [[KWBTE.OB]] shares jumped more than 200 percent as investors recalled its past work with the avian bird flu. A few years ago, the company formed a joint venture to develop Kiwa’s AF-01 anti-viral preventative for avian flu. Investors are bullish on the drugs future prospects, despite the fact that the company only intended to develop it to target animal holding facilities to treat animals.
CONTACT: 888-288-5215 · Please read our Full Disclaimer pertaining to this article.